Not a good buy right now: the stock is in a strong bearish trend (SMA_200 > SMA_20 > SMA_5) with negative MACD momentum and no Intellectia buy signals.
Price is sitting right on key support (S1 ~ 1.508 vs pre-market ~ 1.50); a breakdown risks a quick move toward S2 (~1.312).
While RSI is extremely oversold (RSI_6 ~ 17.8) and could spark a short-lived bounce, the setup is not supported by a confirmed reversal signal, and fundamentals are deteriorating.
With an impatient profile (no scenario provided but explicitly unwilling to wait), the higher-probability move is further downside/whipsaw rather than a clean, immediate rebound trade.
Momentum: MACD histogram is negative (-0.0376) and only slightly contracting → downside momentum is still present, not a confirmed reversal.
Oscillators: RSI_6 at ~17.8 = deeply oversold; this can produce a technical bounce, but oversold can persist in downtrends.
Key levels: Immediate support at S1 1.508 (currently being tested). If it fails, next support is S2 1.312. Upside bounce targets: Pivot 1.825, then R1 2.142.
Pattern-based projection: Similar-pattern analysis suggests modest upside bias over a month (+6.65%), but near-term edges are small (+1.06% next day) and not strong enough to offset the downtrend without confirmation.
Positive Catalysts
increases chances of a short-term reflex bounce.
Neutral/Negative Catalysts
profitability deteriorated sharply: net loss widened and EPS fell significantly.
Financial Performance
Latest quarter: 2025/Q4.
Revenue: 18,532,262 (+2.16% YoY) — modest growth.
Net Income: -3,197,608 (down -172.14% YoY) — losses widened materially.
No analyst rating or price target change data provided; recent trend cannot be verified from the dataset.
Wall Street-style pros: small YoY revenue growth and potential for oversold technical bounce.
Wall Street-style cons: worsening profitability (larger net loss, weaker EPS), margin decline, and a clearly bearish technical trend with no confirmed reversal signal.
Influential/political trading check: No recent congress trading data available; no politician-driven catalyst indicated.
Wall Street analysts forecast CETX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CETX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast CETX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CETX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
